CNE100003NL9
CNE100003NL9
BLOOMAGE BIOTECHNOLOGY CORPORAT
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 4.199.089.275 | 5.370.770.255 | 21.8% |
| Cost of Revenue | 1.245.918.494 | 1.392.561.666 | 10.5% |
| Gross Profit | 2.953.170.781 | 3.978.208.589 | 25.8% |
| 2.493.959.427 | 3.569.088.165 | 30.1% | |
| Operating Income | 459.211.353 | 409.120.424 | 12.2% |
| Pretax Income | 333.802.005 | 213.392.903 | 56.4% |
| Net Income Common Stockholders | 292.058.566 | 174.267.400 | 67.6% |
| -- | -- | -- | |
| -- | -- | -- |